|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
7
|
|
pubmed:dateCreated |
2000-4-21
|
|
pubmed:abstractText |
We postulated that intensification of chemotherapy immediately after remission induction might reduce the leukemic cell burden sufficiently to allow an abbreviated period of antimetabolite therapy.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
Apr
|
|
pubmed:issn |
0732-183X
|
|
pubmed:author |
pubmed-author:BesshoFF,
pubmed-author:HanadaRR,
pubmed-author:HoshiYY,
pubmed-author:HosoyaRR,
pubmed-author:IkutaKK,
pubmed-author:IshimotoKK,
pubmed-author:KanekoTT,
pubmed-author:KoikeK iK,
pubmed-author:MaedaMM,
pubmed-author:ManabeAA,
pubmed-author:MoriTT,
pubmed-author:NakazawaSS,
pubmed-author:OharaAA,
pubmed-author:OhkawaYY,
pubmed-author:OkimotoYY,
pubmed-author:SaitoTT,
pubmed-author:SatoTT,
pubmed-author:ShitaraTT,
pubmed-author:ToyodaYY,
pubmed-author:TsuchidaMM,
pubmed-author:TsunematsuYY
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
18
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
1508-16
|
|
pubmed:dateRevised |
2007-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:10735899-6-Mercaptopurine,
pubmed-meshheading:10735899-Adolescent,
pubmed-meshheading:10735899-Antimetabolites, Antineoplastic,
pubmed-meshheading:10735899-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:10735899-Burkitt Lymphoma,
pubmed-meshheading:10735899-Child,
pubmed-meshheading:10735899-Child, Preschool,
pubmed-meshheading:10735899-Disease-Free Survival,
pubmed-meshheading:10735899-Dose-Response Relationship, Drug,
pubmed-meshheading:10735899-Drug Administration Schedule,
pubmed-meshheading:10735899-Female,
pubmed-meshheading:10735899-Humans,
pubmed-meshheading:10735899-Infant,
pubmed-meshheading:10735899-Male,
pubmed-meshheading:10735899-Methotrexate,
pubmed-meshheading:10735899-Precursor Cell Lymphoblastic Leukemia-Lymphoma,
pubmed-meshheading:10735899-Recurrence,
pubmed-meshheading:10735899-Risk Factors,
pubmed-meshheading:10735899-Treatment Outcome
|
|
pubmed:year |
2000
|
|
pubmed:articleTitle |
Six months of maintenance chemotherapy after intensified treatment for acute lymphoblastic leukemia of childhood.
|
|
pubmed:affiliation |
Department of Oncology, Kanagawa Children's Medical Center, and Department of Pediatrics, Yokohama City University School of Medicine, Yokohama, Japan.
|
|
pubmed:publicationType |
Journal Article,
Clinical Trial,
Research Support, Non-U.S. Gov't
|
